CoreLogic Financials

CoreLogic Stock Summary

CoreLogic competes with Corning Incorporated, Viemed Healthcare, Universal Stainless, Cumberland Pharmaceuticals, and Amgen. CoreLogic, Inc., together with its subsidiaries, provides property information, insight, analytics, and data-enabled solutions in North America, Western Europe, and the Asia Pacific. CoreLogic, Inc. was incorporated in 1894 and is headquartered in Irvine, California. CoreLogic operates under Information Technology Services classification in the United States and is traded on New York Stock Exchange. It employs 5300 people.

CoreLogic Key Financial Ratios

Generally speaking, CoreLogic's financial ratios allow both analysts and investors to convert raw data from CoreLogic's financial statements into concise, actionable information that can be used to evaluate the performance of CoreLogic over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CoreLogic reports annually and quarterly.

CoreLogic Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CoreLogic's current stock value. Our valuation model uses many indicators to compare CoreLogic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CoreLogic competition to find correlations between indicators driving CoreLogic's intrinsic value. More Info.CoreLogic is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies reporting about  0.15  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CoreLogic is roughly  6.54 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CoreLogic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CoreLogic's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CoreLogic's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the CoreLogic information on this page should be used as a complementary analysis to other CoreLogic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

If you are still planning to invest in CoreLogic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CoreLogic's history and understand the potential risks before investing.